Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study
Authors:
Open Access
- 18 January 2012
- journal article
- maternal medicine
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 119 (4) , 484-492
Abstract
Please cite this paper as: Hawkins T, Roberts J, Mangos G, Davis G, Roberts L, Brown M. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG 2012 2012;119:484–492.Objective To examine the relationship between hyperuricaemia, haemoconcentration and maternal and fetal outcomes in hypertensive pregnancies.Design Retrospective analysis of a database of hypertensive pregnancies.Setting St George Hospital, a major obstetric unit in Australia.Population A cohort of 1880 pregnant women without underlying hypertension or renal disease, referred for management of pre‐eclampsia or gestational hypertension.Methods Demographic, clinical and biochemical data at time of referral and delivery were collected for each pregnancy. Women were grouped according to diagnosis (pre‐eclampsia or gestational hypertension) and logistic regression analysis was used to determine the relationship between uric acid, haemoglobin, haematocrit and adverse outcomes; an α level of P < 0.01 was used for statistical significance.Main outcome measures Composites of adverse maternal and fetal outcomes.Results In women with ‘benign’ GH (without proteinuria or any other maternal clinical feature of pre‐eclampsia) gestation‐corrected hyperuricaemia was associated with increased risk of a small‐for‐gestational‐age infant (OR 2.5; 95% CI 1.3–4.8) and prematurity (OR 3.2; 95% CI 1.4–7.2), but not with adverse maternal outcome. In the whole cohort of hypertensive pregnant women (those with pre‐eclampsia or gestational hypertension) the risk of adverse maternal outcome (OR 2.0; 95% CI 1.6–2.4) and adverse fetal outcome (OR 1.8; 95% CI 1.5–2.1) increased with increasing concentration of uric acid. Hyperuricaemia corrected for gestation provided additional strength to these associations. Haemoglobin and haematocrit were not associated with adverse pregnancy outcome.Conclusions Hyperuricaemia in hypertensive pregnancy remains an important finding because it identifies women at increased risk of adverse maternal and particularly fetal outcome; the latter, even in women with gestational hypertension without any other feature of pre‐eclampsia.Keywords
This publication has 30 references indexed in Scilit:
- Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayersAmerican Journal of Physiology-Cell Physiology, 2009
- The Uterine Placental Bed Renin-Angiotensin System in Normal and Preeclamptic PregnancyEndocrinology, 2009
- Increased Xanthine Oxidase in the Skin of Preeclamptic WomenReproductive Sciences, 2009
- Uric Acid Inhibits Placental System A Amino Acid UptakePlacenta, 2009
- Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damageJournal of Perinatal Medicine, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Uric Acid as a Pathogenic Factor in PreeclampsiaPlacenta, 2008
- Extracellular fluid volumes in pregnancy-induced hypertensionJournal Of Hypertension, 1992
- AN EVALUATION OF THE SERUM URIC ACID LEVEL IN PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1963
- THE VALUE OF BLOOD URIC ACID LEVELS IN TOXAEMIA OF PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1956